Previous 10 | Next 10 |
2023-03-17 15:00:38 ET The following slide deck was published by R1 RCM Inc. in conjunction with this event. For further details see: R1 RCM (RCM) presents at Barclays Global Healthcare Conference - Slideshow
2023-03-10 08:47:27 ET The following slide deck was published by R1 RCM Inc. in conjunction with this event. For further details see: R1 RCM (RCM) Presents at the 43rd Annual Cowen Healthcare Conference - Slideshow
Summary The Cloudmed integration appears to be already paying dividends for R1 RCM as a growth accelerator. Projections are for 48% YoY adj. EBITDA growth in FY23. The company looks undervalued at 12.75x forward EBITDA. I reiterate a buy rating, revising my price target higher t...
MURRAY, Utah, March 01, 2023 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ:RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today released its 2022 Environmental, Social, and Governance (ESG) repor...
Shares of the healthcare services company R1 RCM (NASDAQ: RCM) were up by a healthy 10.1% on higher-than-normal volume, as of 11:35 a.m. ET Thursday morning. The company's shares are marching higher in response to a better-than-expected 2022 fourth-quarter earnings report released ahe...
R1 RCM, Inc. (RCM) Q4 2022 Earnings Conference Call February 16, 2023, 8:00 am ET Company Participants Atif Rahim - Head, IR Lee Rivas - CEO Jennifer Williams - EVP & CFO Conference Call Participants Charles Rhyee - Cowen Michael Cherney - Bank of A...
The following slide deck was published by R1 RCM Inc. in conjunction with their 2022 Q4 earnings call. For further details see: R1 RCM Inc. 2022 Q4 - Results - Earnings Call Presentation
R1 RCM press release ( NASDAQ: RCM ): Q4 GAAP EPS of -$0.09 misses by $0.04 . Revenue of $532.8M (+33.6% Y/Y) beats by $13.52M . Adjusted EBITDA of $125.0 million, up $29.9 million or 31.4% compared to the same period last year For 2023, R1 expects to generate: ...
MURRAY, Utah, Feb. 16, 2023 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced results for the three months and year ended December 31, 2022. ...
R1 RCM ( NASDAQ: RCM ) is scheduled to announce Q4 earnings results on Thursday, February 16th, before market open. The consensus EPS Estimate is $0.04 (-63.6% Y/Y) and the consensus Revenue Estimate is $519.28M (+30.2% Y/Y). Over the last 1 year, RCM has beaten EPS estimate...
News, Short Squeeze, Breakout and More Instantly...
MURRAY, Utah, July 15, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced it expects to release financial results for the three months ended ...
2024-07-09 09:00:05 ET George Hill from Deutsche Bank issued a price target of $16.00 for RCM on 2024-07-09 07:36:00. The adjusted price target was set to $16.00. At the time of the announcement, RCM was trading at $12.66. The overall price target consensus is at $19.00 ...
2024-07-08 09:30:06 ET Morgan Stanley analyst issues OVERWEIGHT recommendation for RCM on July 8, 2024 07:50AM ET. The previous analyst recommendation was Overweight. RCM was trading at $10.95 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...